|
|
|
|
| LEADER |
01741nam a2200265Ia 4500 |
| 001 |
10.1093-tbm-ibab103 |
| 008 |
220427s2021 CNT 000 0 und d |
| 020 |
|
|
|a 18696716 (ISSN)
|
| 245 |
1 |
0 |
|a Pivoting during a pandemic: Lessons learned from transitioning a multisite randomized controlled trial to a remote protocol in response to COVID-19
|
| 260 |
|
0 |
|b Oxford University Press
|c 2021
|
| 856 |
|
|
|z View Fulltext in Publisher
|u https://doi.org/10.1093/tbm/ibab103
|
| 520 |
3 |
|
|a THR1VE! is an ongoing multisite randomized clinical trial of a positive psychology intervention designed to treat diabetes distress and improve glycemic outcomes in teens with type 1 diabetes. Due to the COVID-19 pandemic restrictions on clinical research and changes in diabetes clinical care, THR1VE! was adapted from an in-person enrollment protocol to a remote protocol through a series of development and testing strategies. We discuss the process of transitioning the protocol and the demonstrated feasibility of ongoing recruitment, enrollment, and retention outcomes. These findings offer support for a remotely transitioned protocol that has larger applications for ongoing and future clinical research. © 2021 Society of Behavioral Medicine 2021. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
|
| 650 |
0 |
4 |
|a Clinical trial
|
| 650 |
0 |
4 |
|a COVID-19
|
| 650 |
0 |
4 |
|a Protocol
|
| 650 |
0 |
4 |
|a Remote protocol
|
| 650 |
0 |
4 |
|a Type 1 diabetes
|
| 700 |
1 |
|
|a Abadula, F.
|e author
|
| 700 |
1 |
|
|a Inverso, H.
|e author
|
| 700 |
1 |
|
|a Jaser, S.S.
|e author
|
| 700 |
1 |
|
|a Lestourgeon, L.
|e author
|
| 700 |
1 |
|
|a Morrow, T.
|e author
|
| 700 |
1 |
|
|a Parmar, A.
|e author
|
| 700 |
1 |
|
|a Streisand, R.
|e author
|
| 773 |
|
|
|t Translational Behavioral Medicine
|
